Trexquant Investment LP Biotechnology

Trexquant Investment LP

$8.06 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
COGT Cogent Biosciences, Inc.	$435M	$2.16 Million 0.03% of portfolio	277,523	Q4 2024 Added 184.45%
MDXG Mimedx Group, Inc.	$879M	$2.13 Million 0.03% of portfolio	221,262	Q4 2024 Added 29.68%
EWTX Edgewise Therapeutics, Inc.	$1.48B	$2 Million 0.02% of portfolio	74,781	Q4 2024 New
XNCR Xencor Inc	$687M	$1.91 Million 0.02% of portfolio	83,241	Q4 2024 Reduced 59.6%
ARWR Arrowhead Pharmaceuticals, Inc.	$1.46B	$1.9 Million 0.02% of portfolio	100,798	Q4 2024 Reduced 46.01%
URGN Uro Gen Pharma Ltd.	$255M	$1.84 Million 0.02% of portfolio	172,551	Q4 2024 Reduced 36.49%
VRNA Verona Pharma PLC	$3.91B	$1.45 Million 0.02% of portfolio	31,162	Q4 2024 New
TBPH Theravance Biopharma, Inc.	$622M	$1.42 Million 0.02% of portfolio	151,083	Q4 2024 Added 50.7%
TERN Terns Pharmaceuticals, Inc.	$118M	$1.41 Million 0.02% of portfolio	253,247	Q4 2024 Reduced 16.67%
ITOS I Teos Therapeutics, Inc.	$239M	$1.38 Million 0.02% of portfolio	179,966	Q4 2024 Added 267.23%
DNLI Denali Therapeutics Inc.	$1.91B	$1.24 Million 0.02% of portfolio	60,656	Q4 2024 Added 147.23%
NVAX Novavax Inc	$568M	$1.21 Million 0.01% of portfolio	150,085	Q4 2024 Reduced 77.49%
AXSM Axsome Therapeutics, Inc.	$5.22B	$1.2 Million 0.01% of portfolio	14,129	Q4 2024 New
RGNX Regenxbio Inc.	$342M	$1.16 Million 0.01% of portfolio	150,022	Q4 2024 New
STOK Stoke Therapeutics, Inc.	$294M	$1.14 Million 0.01% of portfolio	103,031	Q4 2024 Reduced 36.3%
ADPT Adaptive Biotechnologies Corp	$1.17B	$1.12 Million 0.01% of portfolio	185,868	Q4 2024 New
DAWN Day One Biopharmaceuticals, Inc.	$602M	$1.11 Million 0.01% of portfolio	87,972	Q4 2024 New
VNDA Vanda Pharmaceuticals Inc.	$260M	$1.09 Million 0.01% of portfolio	226,676	Q4 2024 Added 10.87%
VERA Vera Therapeutics, Inc.	$701M	$924,000 0.01% of portfolio	21,864	Q4 2024 Reduced 57.82%
PLRX Pliant Therapeutics, Inc.	$71.6M	$822,000 0.01% of portfolio	62,477	Q4 2024 Reduced 28.06%
ARQT Arcutis Biotherapeutics, Inc.	$968M	$803,000 0.01% of portfolio	57,658	Q4 2024 Reduced 36.08%
SAGE Sage Therapeutics, Inc.	$515M	$785,000 0.01% of portfolio	144,662	Q4 2024 Reduced 17.65%
ENTA Enanta Pharmaceuticals Inc	$121M	$781,000 0.01% of portfolio	135,954	Q4 2024 Added 97.28%
AVXL Anavex Life Sciences Corp.	$744M	$767,000 0.01% of portfolio	71,474	Q4 2024 Added 26.81%
ADMA Adma Biologics, Inc.	$3.98B	$590,000 0.01% of portfolio	34,434	Q4 2024 Reduced 95.81%
ALDX Aldeyra Therapeutics, Inc.	$386M	$571,000 0.01% of portfolio	114,480	Q4 2024 Added 895.48%
ACLX Arcellx, Inc.	$3B	$551,000 0.01% of portfolio	7,237	Q4 2024 New
MNKD Mannkind Corp	$1.31B	$535,000 0.01% of portfolio	83,268	Q4 2024 Reduced 25.63%
LRMR Larimar Therapeutics, Inc.	$102M	$470,000 0.01% of portfolio	123,066	Q4 2024 Reduced 18.56%
XENE Xenon Pharmaceuticals Inc.	$2.15B	$446,000 0.01% of portfolio	11,397	Q4 2024 Reduced 32.59%
SLN Silence Therapeutics PLC	$119M	$438,000 0.01% of portfolio	63,663	Q4 2024 New
RYTM Rhythm Pharmaceuticals, Inc.	$2.98B	$435,000 0.01% of portfolio	7,798	Q4 2024 New
NRIX Nurix Therapeutics, Inc.	$592M	$424,000 0.01% of portfolio	22,527	Q4 2024 Reduced 85.86%
KOD Kodiak Sciences Inc.	$159M	$405,000 0.01% of portfolio	40,736	Q4 2024 New
ABEO Abeona Therapeutics Inc.	$29.8M	$380,000 0.0% of portfolio	68,516	Q4 2024 New
FHTX Foghorn Therapeutics Inc.	$162M	$290,000 0.0% of portfolio	61,598	Q4 2024 Added 1.64%
MGTX Meira G Tx Holdings PLC	$325M	$239,000 0.0% of portfolio	39,348	Q4 2024 New
LQDA Liquidia Corp	$1B	$220,000 0.0% of portfolio	18,740	Q4 2024 New
CRMD Cor Medix Inc.	$293M	$159,000 0.0% of portfolio	19,668	Q4 2024 New
CELC Celcuity Inc.	$156M	$152,000 0.0% of portfolio	11,640	Q4 2024 New
CDXC Chroma Dex Corp.	$519M	$144,000 0.0% of portfolio	27,183	Q4 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	56,563	Q4 2024 Reduced 33.69%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.